Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2019

Feb 14, 2019

30291_dirs_2019-02-14_303b0a99-94da-413f-b141-b05ae5462a60.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2019-02-12

Reporting Person: ALEXANDER SUSAN H (EVP Chief Legal Officer & Sec.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-12 Common Stock M 1348 Acquired 26192 Direct
2019-02-12 Common Stock F 402 $319.43 Disposed 25790 Direct
2019-02-12 Common Stock M 1920 Acquired 27710 Direct
2019-02-12 Common Stock F 619 $319.43 Disposed 27091 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-12 Restricted Stock Unit $0 M 1348 Disposed 2020-02-12 Common Stock (1348) Direct
2019-02-12 Restricted Stock Unit $0 M 1920 Disposed 2021-02-12 Common Stock (1920) Direct
2019-02-12 Restricted Stock Unit $0 J 1448 Disposed 2021-02-12 Common Stock (1448) Direct
2019-02-12 Restricted Stock Unit $0 A 10020 Acquired 2022-02-12 Common Stock (10020) Direct

Footnotes

F1: The restricted stock units will vest in 2 annual installments. One-third will vest on the first anniversary of the grant date and two-thirds will vest on the second anniversary of the grant date.

F2: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

F3: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.